Business Description
Dali Pharmaceutical Co Ltd
ISIN : CNE100002VL4
Share Class Description:
SHSE:603963: Class ACompare
Compare
Traded in other countries / regions
603963.China IPO Date
2017-09-22Description
Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.1 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -1.23 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 4.58 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16 | |||||
3-Year EPS without NRI Growth Rate | -122.4 | |||||
3-Year FCF Growth Rate | -17.5 | |||||
3-Year Book Growth Rate | -6.8 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.51 | |||||
9-Day RSI | 35.65 | |||||
14-Day RSI | 31.76 | |||||
6-1 Month Momentum % | -73.99 | |||||
12-1 Month Momentum % | -72.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.98 | |||||
Quick Ratio | 3.11 | |||||
Cash Ratio | 3.08 | |||||
Days Inventory | 346.15 | |||||
Days Sales Outstanding | 21.8 | |||||
Days Payable | 74.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 3.13 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.62 | |||||
Operating Margin % | -41.69 | |||||
Net Margin % | -34.79 | |||||
FCF Margin % | -49.51 | |||||
ROE % | -5.92 | |||||
ROA % | -4.85 | |||||
ROIC % | -14.54 | |||||
ROC (Joel Greenblatt) % | -22.42 | |||||
ROCE % | -4.75 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 12.68 | |||||
PS Ratio | 8.92 | |||||
PB Ratio | 1.54 | |||||
Price-to-Tangible-Book | 1.7 | |||||
EV-to-EBIT | -19.86 | |||||
EV-to-EBITDA | -19.86 | |||||
EV-to-Revenue | 5.81 | |||||
EV-to-FCF | -11.73 | |||||
Price-to-Projected-FCF | 2.72 | |||||
Price-to-Net-Current-Asset-Value | 3 | |||||
Price-to-Net-Cash | 4.47 | |||||
Earnings Yield (Greenblatt) % | -5.04 | |||||
FCF Yield % | -5.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dali Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 65.703 | ||
EPS (TTM) (Â¥) | -0.104 | ||
Beta | 0.86 | ||
Volatility % | 85.45 | ||
14-Day RSI | 31.76 | ||
14-Day ATR (Â¥) | 0.21791 | ||
20-Day SMA (Â¥) | 2.8715 | ||
12-1 Month Momentum % | -72.19 | ||
52-Week Range (Â¥) | 2.38 - 15.97 | ||
Shares Outstanding (Mil) | 219.7 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Dali Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Dali Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Dali Pharmaceutical Co Ltd Frequently Asked Questions
What is Dali Pharmaceutical Co Ltd(SHSE:603963)'s stock price today?
The current price of SHSE:603963 is ¥2.64. The 52 week high of SHSE:603963 is ¥15.97 and 52 week low is ¥2.38.
When is next earnings date of Dali Pharmaceutical Co Ltd(SHSE:603963)?
The next earnings date of Dali Pharmaceutical Co Ltd(SHSE:603963) is .
Does Dali Pharmaceutical Co Ltd(SHSE:603963) pay dividends? If so, how much?
Dali Pharmaceutical Co Ltd(SHSE:603963) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |